Very much agree @taylorstjames that was one of my key takeaways - not only will the milestone payments and royalties be flowing in to MSB, but the cost of future clinical development will not be flowing out.
Last time I checked when revenue exceeds costs it equals profits!! I know that is an over-simplification but effectively that was the primary message from the announcements. I've been a holder since 2016 and remember when most of the discussion was about partnerships not agvhd or covid. Well here we are with a billion dollar partnership landed. This story is just beginning - the heavy lifting has been done and the market is waking up to the significance of the pipeline.
Please form your own view based on your own research.
Very much agree @taylorstjames that was one of my key takeaways...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 98.5¢ | 98.5¢ | 96.0¢ | $2.168M | 2.226M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16000 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 86854 | 7 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |